Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118591

Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells.

H Mashima, H Ohnishi, K Wakabayashi, T Mine, J Miyagawa, T Hanafusa, M Seno, H Yamada, and I Kojima

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Mashima, H. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Ohnishi, H. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Wakabayashi, K. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Mine, T. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Miyagawa, J. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Hanafusa, T. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Seno, M. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Yamada, H. in: JCI | PubMed | Google Scholar

Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.

Find articles by Kojima, I. in: JCI | PubMed | Google Scholar

Published April 1, 1996 - More info

Published in Volume 97, Issue 7 on April 1, 1996
J Clin Invest. 1996;97(7):1647–1654. https://doi.org/10.1172/JCI118591.
© 1996 The American Society for Clinical Investigation
Published April 1, 1996 - Version history
View PDF
Abstract

Rat pancreatic AR42J cells possess exocrine and neuroendocrine properties. Activin A induces morphological changes and converts them into neuron-like cells. In activin-treated cells, mRNA for pancreatic polypeptide (PP) but not that for either insulin or glucagon was detected by reverse transcription-PCR. About 25% of the cells were stained by anti-PP antibody. When AR42J cells were incubated with betacellulin, a small portion of the cells were stained positively with antiinsulin and anti-PP antibodies. The effect of betacellulin was dose dependent, being maximal at 2 nM. Approximately 4% of the cells became insulin positive at this concentration, and mRNAs for insulin and PP were detected. When AR42J cells were incubated with a combination of betacellulin and activin A, approximately 10% of the cells became insulin positive. Morphologically, the insulin-positive cells were composed of two types of cells: neuron-like and round-shaped cells. Immunoreactive PP was found in the latter type of cells. The mRNAs for insulin, PP, glucose transporter 2, and glucokinase, but not glucagon, were detected. Depolarizing concentration of potassium, tolbutamide, carbachol, and glucagon-like peptide-1 stimulated the release of immunoreactive insulin. These results indicate that betacellulin and activin A convert amylase-secreting AR42J cells into cells secreting insulin. AR42J cells provide a model system to study the formation of pancreatic endocrine cells.

Version history
  • Version 1 (April 1, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts